This Article Full Text Full Text (PDF) All Versions of this Article: 27/9/2022    most recent ATVBAHA.107.148403v2 ATVBAHA.107.148403v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Weibel, G. L. Articles by Rothblat, G. H. Search for Related Content PubMed PubMed Citation Articles by Weibel, G. L. Articles by Rothblat, G. H. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Substance via MeSH

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2007;27:2022.)
© 2007 American Heart Association, Inc.

Atherosclerosis and Lipoproteins

Wild-Type ApoA-I and the Milano Variant Have Similar Abilities to Stimulate Cellular Lipid Mobilization and Efflux

Ginny L. Weibel; Eric T. Alexander; Michelle R. Joshi; Daniel J. Rader; Sissel Lund-Katz; Michael C. Phillips; George H. Rothblat

From the Division of Gasteroenterology and Nutrition (G.L.W., E.T.A., M.R.J., S.L-K., M.C.P., G.H.R.), The Children’s Hospital of Philadelphia, and the Department of Medicine (D.J.R.), University of Pennsylvania School of Medicine, Philadelphia, Pa.

Correspondence to Ginny L. Weibel, Division of Gasteroenterology and Nutrition, The Children’s Hospital of Philadelphia, Philadelphia, PA 19104-4399. E-mail weibel{at}email.chop.edu

Objective— The present study is a comparative investigation of cellular lipid mobilization and efflux to lipid-free human apoA-I and apoA-I_Milano, reconstituted high-density lipoprotein (rHDL) particles containing these proteins and serum isolated from mice expressing human apoA-I or apoA-I_Milano.

Methods and Results— Cholesterol and phospholipid efflux to these acceptors was measured in cell systems designed to assess the contributions of ATP-binding cassette A1 (ABCA1), scavenger receptor type BI (SRBI), and cellular lipid content to cholesterol and phospholipid efflux. Acceptors containing the Milano variant of apoA-I showed no functional increase in lipid efflux in all assays when compared with wild-type apoA-I. In fact, in some systems, acceptors containing the Milano variant of apoA-I promoted significantly less efflux than the acceptors containing wild-type apoA-I (apoA-I_wt). Additionally, intracellular cholesteryl ester hydrolysis in macrophage foam cells was not different in the presence of either apoA-I_Milano or apoA-I_wt.

Conclusion— Collectively these studies suggest that if the Milano variant of apoA-I offers greater atheroprotection than wild-type apoA-I, it is not attributable to greater cellular lipid mobilization.

The present study is a comparative investigation of cellular lipid mobilization to human apoA-I and apoA-I_Milano. Efflux was measured in cell systems designed to assess the contributions ABCA1 and SR-BI. Acceptors containing the Milano variant of apoA-I showed no functional increase in lipid efflux when compared with wild-type apoA-I.

Key Words: apolipoprotein • A-I • HDL • cholesterol efflux • apoA-I_Milano

This article has been cited by other articles:

				P. T. Duong, G. L. Weibel, S. Lund-Katz, G. H. Rothblat, and M. C. Phillips Characterization and properties of pre{beta}-HDL particles formed by ABCA1-mediated cellular lipid efflux to apoA-I J. Lipid Res., May 1, 2008; 49(5): 1006 - 1014. [Abstract] [Full Text] [PDF]